1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 TKI 1.2.3 Multitarget Inhibitor 1.2.4 Others 1.3 Market by Application 1.3.1 Global Small Molecule Targeted Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Liver Cancer 1.3.3 Colorectal Cancer 1.3.4 Lung Cancer 1.3.5 Gastric Cancer 1.3.6 Breast Cancer 1.3.7 Esophageal Cancer 1.3.8 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Small Molecule Targeted Therapy Market Perspective (2016-2027) 2.2 Small Molecule Targeted Therapy Growth Trends by Regions 2.2.1 Small Molecule Targeted Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Small Molecule Targeted Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Small Molecule Targeted Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Small Molecule Targeted Therapy Industry Dynamic 2.3.1 Small Molecule Targeted Therapy Market Trends 2.3.2 Small Molecule Targeted Therapy Market Drivers 2.3.3 Small Molecule Targeted Therapy Market Challenges 2.3.4 Small Molecule Targeted Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Small Molecule Targeted Therapy Players by Revenue 3.1.1 Global Top Small Molecule Targeted Therapy Players by Revenue (2016-2021) 3.1.2 Global Small Molecule Targeted Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Small Molecule Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Small Molecule Targeted Therapy Revenue 3.4 Global Small Molecule Targeted Therapy Market Concentration Ratio 3.4.1 Global Small Molecule Targeted Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Therapy Revenue in 2020 3.5 Small Molecule Targeted Therapy Key Players Head office and Area Served 3.6 Key Players Small Molecule Targeted Therapy Product Solution and Service 3.7 Date of Enter into Small Molecule Targeted Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Small Molecule Targeted Therapy Breakdown Data by Type 4.1 Global Small Molecule Targeted Therapy Historic Market Size by Type (2016-2021) 4.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2022-2027) 5 Small Molecule Targeted Therapy Breakdown Data by Application 5.1 Global Small Molecule Targeted Therapy Historic Market Size by Application (2016-2021) 5.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Small Molecule Targeted Therapy Market Size (2016-2027) 6.2 North America Small Molecule Targeted Therapy Market Size by Type 6.2.1 North America Small Molecule Targeted Therapy Market Size by Type (2016-2021) 6.2.2 North America Small Molecule Targeted Therapy Market Size by Type (2022-2027) 6.2.3 North America Small Molecule Targeted Therapy Market Size by Type (2016-2027) 6.3 North America Small Molecule Targeted Therapy Market Size by Application 6.3.1 North America Small Molecule Targeted Therapy Market Size by Application (2016-2021) 6.3.2 North America Small Molecule Targeted Therapy Market Size by Application (2022-2027) 6.3.3 North America Small Molecule Targeted Therapy Market Size by Application (2016-2027) 6.4 North America Small Molecule Targeted Therapy Market Size by Country 6.4.1 North America Small Molecule Targeted Therapy Market Size by Country (2016-2021) 6.4.2 North America Small Molecule Targeted Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Small Molecule Targeted Therapy Market Size (2016-2027) 7.2 Europe Small Molecule Targeted Therapy Market Size by Type 7.2.1 Europe Small Molecule Targeted Therapy Market Size by Type (2016-2021) 7.2.2 Europe Small Molecule Targeted Therapy Market Size by Type (2022-2027) 7.2.3 Europe Small Molecule Targeted Therapy Market Size by Type (2016-2027) 7.3 Europe Small Molecule Targeted Therapy Market Size by Application 7.3.1 Europe Small Molecule Targeted Therapy Market Size by Application (2016-2021) 7.3.2 Europe Small Molecule Targeted Therapy Market Size by Application (2022-2027) 7.3.3 Europe Small Molecule Targeted Therapy Market Size by Application (2016-2027) 7.4 Europe Small Molecule Targeted Therapy Market Size by Country 7.4.1 Europe Small Molecule Targeted Therapy Market Size by Country (2016-2021) 7.4.2 Europe Small Molecule Targeted Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Small Molecule Targeted Therapy Market Size (2016-2027) 8.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type 8.2.1 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application 8.3.1 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region 8.4.1 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Small Molecule Targeted Therapy Market Size (2016-2027) 9.2 Latin America Small Molecule Targeted Therapy Market Size by Type 9.2.1 Latin America Small Molecule Targeted Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Small Molecule Targeted Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Small Molecule Targeted Therapy Market Size by Type (2016-2027) 9.3 Latin America Small Molecule Targeted Therapy Market Size by Application 9.3.1 Latin America Small Molecule Targeted Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Small Molecule Targeted Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Small Molecule Targeted Therapy Market Size by Application (2016-2027) 9.4 Latin America Small Molecule Targeted Therapy Market Size by Country 9.4.1 Latin America Small Molecule Targeted Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Small Molecule Targeted Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Small Molecule Targeted Therapy Market Size (2016-2027) 10.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type 10.2.1 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application 10.3.1 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country 10.4.1 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Astrazeneca 11.1.1 Astrazeneca Company Details 11.1.2 Astrazeneca Business Overview 11.1.3 Astrazeneca Small Molecule Targeted Therapy Introduction 11.1.4 Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.1.5 Astrazeneca Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Small Molecule Targeted Therapy Introduction 11.2.4 Novartis Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Millennium Pharmaceuticals 11.3.1 Millennium Pharmaceuticals Company Details 11.3.2 Millennium Pharmaceuticals Business Overview 11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Therapy Introduction 11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.3.5 Millennium Pharmaceuticals Recent Development 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Small Molecule Targeted Therapy Introduction 11.4.4 Bayer Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.4.5 Bayer Recent Development 11.5 Exelixis 11.5.1 Exelixis Company Details 11.5.2 Exelixis Business Overview 11.5.3 Exelixis Small Molecule Targeted Therapy Introduction 11.5.4 Exelixis Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.5.5 Exelixis Recent Development 11.6 Abbvie 11.6.1 Abbvie Company Details 11.6.2 Abbvie Business Overview 11.6.3 Abbvie Small Molecule Targeted Therapy Introduction 11.6.4 Abbvie Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.6.5 Abbvie Recent Development 11.7 Boehringer-Ingelheim 11.7.1 Boehringer-Ingelheim Company Details 11.7.2 Boehringer-Ingelheim Business Overview 11.7.3 Boehringer-Ingelheim Small Molecule Targeted Therapy Introduction 11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.7.5 Boehringer-Ingelheim Recent Development 11.8 Eisai 11.8.1 Eisai Company Details 11.8.2 Eisai Business Overview 11.8.3 Eisai Small Molecule Targeted Therapy Introduction 11.8.4 Eisai Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.8.5 Eisai Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Details 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Small Molecule Targeted Therapy Introduction 11.9.4 Pfizer Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.9.5 Pfizer Recent Development 11.10 Bristol-Myers Squibb 11.10.1 Bristol-Myers Squibb Company Details 11.10.2 Bristol-Myers Squibb Business Overview 11.10.3 Bristol-Myers Squibb Small Molecule Targeted Therapy Introduction 11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.10.5 Bristol-Myers Squibb Recent Development 11.11 Roche 11.11.1 Roche Company Details 11.11.2 Roche Business Overview 11.11.3 Roche Small Molecule Targeted Therapy Introduction 11.11.4 Roche Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.11.5 Roche Recent Development 11.12 Bettapharma 11.12.1 Bettapharma Company Details 11.12.2 Bettapharma Business Overview 11.12.3 Bettapharma Small Molecule Targeted Therapy Introduction 11.12.4 Bettapharma Revenue in Small Molecule Targeted Therapy Business (2016-2021) 11.12.5 Bettapharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Small Molecule Targeted Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of TKI Table 3. Key Players of Multitarget Inhibitor Table 4. Key Players of Others Table 5. Global Small Molecule Targeted Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Small Molecule Targeted Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Small Molecule Targeted Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Small Molecule Targeted Therapy Market Share by Regions (2016-2021) Table 9. Global Small Molecule Targeted Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Small Molecule Targeted Therapy Market Share by Regions (2022-2027) Table 11. Small Molecule Targeted Therapy Market Trends Table 12. Small Molecule Targeted Therapy Market Drivers Table 13. Small Molecule Targeted Therapy Market Challenges Table 14. Small Molecule Targeted Therapy Market Restraints Table 15. Global Small Molecule Targeted Therapy Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Small Molecule Targeted Therapy Market Share by Players (2016-2021) Table 17. Global Top Small Molecule Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Therapy as of 2020) Table 18. Ranking of Global Top Small Molecule Targeted Therapy Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Therapy Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Small Molecule Targeted Therapy Product Solution and Service Table 22. Date of Enter into Small Molecule Targeted Therapy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 25. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2016-2021) Table 26. Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Small Molecule Targeted Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Small Molecule Targeted Therapy Revenue Market Share by Application (2016-2021) Table 30. Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Small Molecule Targeted Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 33. North America Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 35. North America Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 62. Astrazeneca Company Details Table 63. Astrazeneca Business Overview Table 64. Astrazeneca Small Molecule Targeted Therapy Product Table 65. Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 66. Astrazeneca Recent Development Table 67. Novartis Company Details Table 68. Novartis Business Overview Table 69. Novartis Small Molecule Targeted Therapy Product Table 70. Novartis Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 71. Novartis Recent Development Table 72. Millennium Pharmaceuticals Company Details Table 73. Millennium Pharmaceuticals Business Overview Table 74. Millennium Pharmaceuticals Small Molecule Targeted Therapy Product Table 75. Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 76. Millennium Pharmaceuticals Recent Development Table 77. Bayer Company Details Table 78. Bayer Business Overview Table 79. Bayer Small Molecule Targeted Therapy Product Table 80. Bayer Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 81. Bayer Recent Development Table 82. Exelixis Company Details Table 83. Exelixis Business Overview Table 84. Exelixis Small Molecule Targeted Therapy Product Table 85. Exelixis Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 86. Exelixis Recent Development Table 87. Abbvie Company Details Table 88. Abbvie Business Overview Table 89. Abbvie Small Molecule Targeted Therapy Product Table 90. Abbvie Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 91. Abbvie Recent Development Table 92. Boehringer-Ingelheim Company Details Table 93. Boehringer-Ingelheim Business Overview Table 94. Boehringer-Ingelheim Small Molecule Targeted Therapy Product Table 95. Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 96. Boehringer-Ingelheim Recent Development Table 97. Eisai Company Details Table 98. Eisai Business Overview Table 99. Eisai Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 100. Eisai Recent Development Table 101. Pfizer Company Details Table 102. Pfizer Business Overview Table 103. Pfizer Small Molecule Targeted Therapy Product Table 104. Pfizer Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 105. Pfizer Recent Development Table 106. Bristol-Myers Squibb Company Details Table 107. Bristol-Myers Squibb Business Overview Table 108. Bristol-Myers Squibb Small Molecule Targeted Therapy Product Table 109. Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 110. Bristol-Myers Squibb Recent Development Table 111. Roche Company Details Table 112. Roche Business Overview Table 113. Roche Small Molecule Targeted Therapy Product Table 114. Roche Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 115. Roche Recent Development Table 116. Bettapharma Company Details Table 117. Bettapharma Business Overview Table 118. Bettapharma Small Molecule Targeted Therapy Product Table 119. Bettapharma Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million) Table 120. Bettapharma Recent Development Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Small Molecule Targeted Therapy Market Share by Type: 2020 VS 2027 Figure 2. TKI Features Figure 3. Multitarget Inhibitor Features Figure 4. Others Features Figure 5. Global Small Molecule Targeted Therapy Market Share by Application: 2020 VS 2027 Figure 6. Liver Cancer Case Studies Figure 7. Colorectal Cancer Case Studies Figure 8. Lung Cancer Case Studies Figure 9. Gastric Cancer Case Studies Figure 10. Breast Cancer Case Studies Figure 11. Esophageal Cancer Case Studies Figure 12. Others Case Studies Figure 13. Small Molecule Targeted Therapy Report Years Considered Figure 14. Global Small Molecule Targeted Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Small Molecule Targeted Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Small Molecule Targeted Therapy Market Share by Regions: 2020 VS 2027 Figure 17. Global Small Molecule Targeted Therapy Market Share by Regions (2022-2027) Figure 18. Global Small Molecule Targeted Therapy Market Share by Players in 2020 Figure 19. Global Top Small Molecule Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Therapy as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Targeted Therapy Revenue in 2020 Figure 21. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2016-2021) Figure 22. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2022-2027) Figure 23. North America Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Small Molecule Targeted Therapy Market Share by Type (2016-2027) Figure 25. North America Small Molecule Targeted Therapy Market Share by Application (2016-2027) Figure 26. North America Small Molecule Targeted Therapy Market Share by Country (2016-2027) Figure 27. United States Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Small Molecule Targeted Therapy Market Share by Type (2016-2027) Figure 31. Europe Small Molecule Targeted Therapy Market Share by Application (2016-2027) Figure 32. Europe Small Molecule Targeted Therapy Market Share by Country (2016-2027) Figure 33. Germany Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Small Molecule Targeted Therapy Market Share by Type (2016-2027) Figure 41. Asia-Pacific Small Molecule Targeted Therapy Market Share by Application (2016-2027) Figure 42. Asia-Pacific Small Molecule Targeted Therapy Market Share by Region (2016-2027) Figure 43. China Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Small Molecule Targeted Therapy Market Share by Type (2016-2027) Figure 51. Latin America Small Molecule Targeted Therapy Market Share by Application (2016-2027) Figure 52. Latin America Small Molecule Targeted Therapy Market Share by Country (2016-2027) Figure 53. Mexico Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Small Molecule Targeted Therapy Market Share by Type (2016-2027) Figure 57. Middle East & Africa Small Molecule Targeted Therapy Market Share by Application (2016-2027) Figure 58. Middle East & Africa Small Molecule Targeted Therapy Market Share by Country (2016-2027) Figure 59. Turkey Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Astrazeneca Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 64. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 65. Bayer Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 66. Exelixis Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 67. Abbvie Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 68. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 69. Eisai Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 72. Roche Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 73. Bettapharma Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Astrazeneca Novartis Millennium Pharmaceuticals Bayer Exelixis Abbvie Boehringer-Ingelheim Eisai Pfizer Bristol-Myers Squibb Roche Bettapharma